Companies developing some of the most-innovative medical devices are launching them abroad first, well before they reach U.S. shores, according to a new study by researchers at Northwestern University. The culprit behind this perceived technology drain? The researchers point to the Food and Drug Administration (FDA). Their survey of more than 350 professionals found that two-thirds of small medical device companies engaged in developing new products are obtaining approvals in Europe first. This suggests, they said, a “delayed market entry” in the United States.
